Clinical Trial Update: A Study of Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple Countries

View source ↗

Summary

A study evaluating lanadelumab for hereditary angioedema in children across multiple countries is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Takhzyro (lanadelumab)

Snippet

Sponsor: Takeda | Conditions: Hereditary Angioedema (HAE) | Status: RECRUITING